Of these twenty, three showed evidence of association with LoF variants for overall breast cancer (ZFAND1, TYRO3, TMEM206/PACC1), and a further six with breast cancer subtypes (DNAH11, PARP2, LAMC3, MTMR11, EPN3, SLC22A10). This evidence concerns the gene PARP2 and breast cancer.